Flumazenil: Difference between revisions
Jump to navigation
Jump to search
(Created page with "==Section 8 - MEDICATION GUIDELINES== ===ANTAGONISTS === ====Flumazenil (ROMAZICON) / Antagonist==== '''DESCRIPTION''' * It is a benzodiazepine antagonist. '''INDICATIONS'''...") |
No edit summary |
||
| Line 6: | Line 6: | ||
* It is a benzodiazepine antagonist. | * It is a benzodiazepine antagonist. | ||
'''INDICATIONS''' | '''INDICATIONS''' | ||
* Inadvertent overmedication with [[ | * Inadvertent overmedication with [[Versed|VERSED]] or [[Valium|VALIUM]] | ||
'''CONTRAINDICATIONS''' | '''CONTRAINDICATIONS''' | ||
* Hypersensitivity to the medication, Tricyclic antidepressant overdoses. | * Hypersensitivity to the medication, Tricyclic antidepressant overdoses. | ||
Latest revision as of 14:04, 24 April 2020
Section 8 - MEDICATION GUIDELINES
ANTAGONISTS
Flumazenil (ROMAZICON) / Antagonist
DESCRIPTION
- It is a benzodiazepine antagonist.
INDICATIONS
CONTRAINDICATIONS
- Hypersensitivity to the medication, Tricyclic antidepressant overdoses.
PRECAUTIONS
- Use with caution in cases of mixed overdose, adverse reactions include arrhythmias and seizures.
DOSAGE
- Usual dosage is 0.2 mg IV over 15 seconds; wait 45 seconds, then give 0.2 mg if consciousness does not occur; may be repeated 60 second intervals prn, up to 4 additional doses-max 1 mg.
- Refer to Handtevy System for pediatric specific dosages
- Premie - 5 y/o: 0.01 mg/kg
- 6 years and older: 0.2 mg